Evidence map›Paper›PMID 40514388›Full record

ArticleMolecular psychiatry2025

Directing negative emotional states through parallel genetically-distinct basolateral amygdala pathways to ventral striatum subregions.

Sarah E Sniffen, Sang Eun Ryu, Milayna M Kokoska, Janardhan Bhattarai, Yingqi Wang, Ellyse R Thomas, Graylin M Skates, Natalie L Johnson, Andy A Chavez, Sophia R Iaconis and 4 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Sarah E Sniffen *Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.ORCID http://orcid.org/0009-0003-1298-457X
Sang Eun Ryu *Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Milayna M KokoskaDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Janardhan BhattaraiDepartment of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-4102-1380
Yingqi WangDepartment of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0009-0000-9480-7179
Ellyse R ThomasDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Graylin M SkatesDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.ORCID http://orcid.org/0009-0006-6711-2025
Natalie L JohnsonDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Andy A ChavezDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Sophia R IaconisDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA.
Emma JankeDepartment of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Yun-Feng ZhangDepartment of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0001-6324-4115
Minghong MaDepartment of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Daniel W WessonDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, Florida Chemical Senses Institute, Gainesville, FL, 32610, USA. danielwesson@ufl.edu.ORCID http://orcid.org/0000-0002-3192-3866

Funding

Striatal mechanisms for e-cigarette reinforcement by flavorantsR01DA049545 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DE BIASI, MARIELLA, MA, MINGHONG · 2019 to 2023
$3.2M
Linking Synucleinopathy and Dysfunction of Olfactory PathwaysR01DC016519 · NIDCD · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN, WESSON, DANIEL W · 2017 to 2021
$2.8M
Novel Role of a Ventral Striatal Circuit in Motor ControlR01NS117061 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI FUCCILLO, MARC V, MA, MINGHONG · 2021 to 2025
$2.4M
INTER-REGIONAL CODING OF ODOR VALENCE BY NEURAL ENSEMBLESR01DC014443 · NIDCD · UNIVERSITY OF FLORIDA · PI WESSON, DANIEL W · 2015 to 2019
$2.3M
Circuitry and function of ventral striatum subregionsR01DA049449 · NIDA · UNIVERSITY OF FLORIDA · PI MA, MINGHONG, WESSON, DANIEL W · 2020 to 2024
$2.1M
Training Program in Chemosensory ScienceT32DC015994 · NIDCD · UNIVERSITY OF FLORIDA · PI Daniel W Wesson · 2018 to 2026
$1.4M
Harnessing biological rhythms for a resilient social motif generatorR34DA059718 · NIDA · UNIVERSITY OF FLORIDA · PI PADILLA COREANO, NANCY, SAXENA, SHREYA · 2024 to 2025
$676k
Circuitry and function of the NLOT in olfactory-guided behaviorsR21DC019193 · NIDCD · UNIVERSITY OF PENNSYLVANIA · PI BHATTARAI, JANARDHAN PRASAD · 2021 to 2023
$477k
Basolateral amygdala support of odor valence learningF31DC021888 · NIDCD · UNIVERSITY OF FLORIDA · PI Sarah Elizabeth Sniffen · 2024 to 2026
$106k
Olfactory Mechanisms Supporting Attraction to e-Cigarette OdorsF31DC020364 · NIDCD · UNIVERSITY OF FLORIDA · PI JOHNSON, NATALIE LEWIS · 2022 to 2023
$90k
NIDA NIH HHS R01 DA049449NIDA NIH HHS R01 DA049545NIDA NIH HHS R34 DA059718NIDCD NIH HHS F31 DC020364NIDCD NIH HHS F31 DC021888NIDCD NIH HHS R01 DC014443NIDCD NIH HHS R01 DC016519NIDCD NIH HHS R21 DC019193NIDCD NIH HHS T32 DC015994NINDS NIH HHS R01 NS117061U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DC014443U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS117061U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) DC019193U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) F31DC020364U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) F31DC021888U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) T32015994U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) T32DC015994U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA049449U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA049545U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R34DA059718
6 · The paper itself

Abstract

Distinct basolateral amygdala (BLA) cell populations influence emotions in manners thought important for anxiety and anxiety disorders. The BLA contains numerous cell types which can broadcast information into structures that may elicit changes in emotional states and behaviors. BLA excitatory neurons can be divided into two main classes, one of which expresses Ppp1r1b (encoding protein phosphatase 1 regulatory inhibitor subunit 1B) which is downstream of the genes encoding the D1 and D2 dopamine receptors (Drd1 and Drd2 respectively). The role of Drd1+ or Drd2+ BLA neurons in learned and unlearned emotional responses is unknown. Here, we identified that the Drd1+ and Drd2+ BLA neuron populations form two parallel pathways for communication with the ventral striatum. These neurons arise from the basal nucleus of the BLA, innervate the entire space of the ventral striatum, and are capable of exciting ventral striatum neurons. Further, through two separate behavioral assays, we found that the Drd1+ and Drd2+ parallel pathways distinctly influence both learned and unlearned emotional states when they are activated or suppressed and do so depending upon where they synapse in the ventral striatum - with unique contributions of Drd1+ and Drd2+ circuitry on negative emotional states. Overall, these results contribute to a model whereby parallel, genetically-distinct BLA to ventral striatum circuits inform emotional states in a projection-specific manner.

Indexed as

Basolateral Nuclear ComplexEmotionsVentral StriatumAmygdalaAnimalsAnxietyDopamine and cAMP-Regulated Phosphoprotein 32MaleMiceMice, Inbred C57BLMice, TransgenicNeural PathwaysNeuronsReceptors, Dopamine D1Receptors, Dopamine D2Dopamine and cAMP-Regulated Phosphoprotein 32Drd1 protein, mouseDRD2 protein, mousePpp1r1b protein, mouseReceptors, Dopamine D1Receptors, Dopamine D2

Identifiers

PMID40514388
PMCPMC12436152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.